NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 81 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 2,040.10 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,000 | +20.0% | 46,262 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -54.5% | 46,262 | 0.0% | 0.00% | – |
| Q3 2018 | $11,000 | 0.0% | 46,262 | 0.0% | 0.00% | – |
| Q2 2018 | $11,000 | -35.3% | 46,262 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $17,000 | 0.0% | 46,262 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $17,000 | -10.5% | 46,262 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $19,000 | -20.8% | 46,262 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $24,000 | -11.1% | 46,262 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $27,000 | -6.9% | 46,262 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $29,000 | -31.0% | 46,262 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $42,000 | +68.0% | 46,262 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $25,000 | -43.2% | 46,262 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $44,000 | -29.0% | 46,262 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $62,000 | -41.0% | 46,262 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $105,000 | +41.9% | 46,262 | 0.0% | 0.00% | +100.0% |
| Q2 2015 | $74,000 | 0.0% | 46,262 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $74,000 | -14.9% | 46,262 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $87,000 | – | 46,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|